The canine DLC 01 cell line derives from a lymph node of a dog with Sé zary syndrome. The DLC 01 cell phenotype is CD4 ؊ , CD8
Introduction
Cutaneous T cell lymphomas (CTCL) are a group of rare disorders which include mycosis fungoides (MF) and Sézary syndrome (SS). SS is defined by generalized lymphadenopathy and circulating neoplastic lymphocytes with atypical cerebriform nuclei. Diseases related to MF and SS have been described in dogs. [1] [2] [3] [4] [5] [6] However, the immunophenotype of the epitheliotropic T cells in canine CTCL are TCR ␥␦ CD8 [7] [8] [9] [10] whereas in human MF and SS, they are TCR ␣␤ CD4 + in the vast majority of cases. [11] [12] [13] [14] Occasional reports of human CD8 + CTCL have also been described, essentially in Pagetoid reticulosis, a rare form of CTCL characterized by a strong epidermotropic lymphoid infiltrate. [15] [16] [17] Established cell lines are an important tool for the study of molecular mechanisms involved in the transformation process induced by carcinogens, the phenotypic properties of transformed hematopoietic cells, and the regulatory mechanisms involved in cell replication and differentiation. Large numbers of human leukemia and lymphoma cell lines have been established, [18] [19] [20] [21] and it has been demonstrated that some human hematopoietic cell lines can be induced to differentiate in vitro by low molecular weight products such as dimethylsulfoxide (DMSO), phorbol 12-myristate 13-acetate (PMA) and all-trans retinol acetate (RA). In this work, we report the first characterization of a canine lymphoma T-CD8 + cell line, named DLC 01 (dog lymphoma cells) growing spontaneously, derived from fresh lymph node cells taken from a dog suffering from SS. Moreover, this paper reports the detection of a type-C retrovirus in the DLC 01 cell line, and the effects of DMSO, PMA and RA on surface molecule modulation and retrovirus release. 
Materials and methods

Case history
A 13-year-old male crossbred dog (MAN . . .) was referred to the Unité de Dermatologie, Ecole Vétérinaire de Lyon, for evaluation of gingivitis that had developed during the 6 months before referral. Physical examination revealed a febrile animal, and the enlargement of several peripheral lymph nodes. Examination of obvious skin disorders revealed a diffuse cutaneous erythema, scales, crusts and ulceration of the mucous membranes, and of all the mucocutaneous junctions. The complete blood count showed leukocytosis (59 000/mm 3 ) due to lymphocytosis (15 300/mm 3 ) and neutrophilia (39 530/mm 3 ) , with a normal distribution of other leukocytes. Examination of cells from biopsy of the mucocutaneous junctions, the skin and the lymph node revealed malignant convoluted T cells. Immunohistochemical study of the skin and lymph nodes showed that the lymphoid cells were CD3
+ , CD8
+ . An epitheliotropism infiltrate associated with atypical lymphocytes is a feature of CTCL. Flow cytometry analysis of peripheral blood showed 52% were CD8 + , which indicated SS, the leukemic form of CTCL.
Establishment and characterization of cell lines: chemicals and hematopoietic growth factors
(Retinoid acid) RA, aphidicolin (5 g/ml), interleukin-2 (IL-2, 100 IU/ml), propidium iodide (PI), phytohemagglutinin (PHA, 5 g/ml) and ARNase (250 g/ml) were purchased from Sigma Chemicals (St Louis, MO, USA), PMA from Fluka ChemikaBiochemika (Buchs, Switzerland), DMSO from Merck-Schuchardt (Honenbrunn, Germany). In each experiment using PHA and RA, controls were run of diluent which had no effect on cell proliferation.
Cell cultures
The lymphocytes isolated from the lymph node suspension taken from the (MAN . . .) dog were incubated at a final concentration of 10 6 /ml in RPMI 1640 culture medium supplemented with 20% heat-inactivated fetal calf serum (FCS) (GibcoBRL, Cergy Pontoise, France), pimaricine (2.5%), l-glutamine (2 mm), sodium pyruvate (2 mm), penicillin (100 IU/ml) and streptomycin (100 g/ml), and maintained in 24-well plates at 37°C in an atmosphere containing 5% CO 2 . No growth factors or feeder cells were used. The cells were fed twice weekly by partial replacement of the medium. After 4 to 6 weeks, continuous growth of the cells was observed, and a new cell line was confirmed after 12 weeks of culture. The cell line was cloned by limited dilution technique. After three procedures of cloning dilution, one of these clones was selec-ted, and named DLC 01. To determine growth curves, cells were seeded at 0.5 × 10 5 cells/ml in 10 ml. Cell counts were carried out every day for 2 weeks, using the trypan blue dye exclusion method (GibcoBRL). DLC 01/Nude, a transplantable ascites tumor derived from DLC 01, was passed weekly through the peritoneal cavity of Nude/mice. Furthermore, we established three different short-term lymphocyte culture as controls. Firstly, mycosis fungoides cells were derived from a lymph node suspension taken from another dog (DOL . . .). Secondly, peripheral blood mononuclear cells from healthy dogs were enriched and isolated by density gradient separation as previously described, 22 and depleted of adherent cells by overnight adherence to plastic, in a complete culture medium, at 10 6 cells/ml. The mononuclear cells were incubated at a final concentration of 2 × 10 6 /ml in RPMI 1640 medium supplemented with 20% heat-inactivated FCS. Thirdly, short-term IL2-dependent cell lines (STCL) were established from mitogen-stimulated PBMC taken from healthy dogs. An STCL treated with 0.5% DMSO was named STCL1. In all experiments the viability of the isolated lymphocytes, as assessed by trypan blue dye exclusion, was always greater than 95% at the time of culture. The morphology of the cells was evaluated from cytospin slide preparations stained with May-Grü nwald-Giemsa and electron microscopy ultrathin sections.
Cytogenetic analysis
Karyotypic analysis of DLC 01 cells was carried out on a standard heat-Giemsa RHG-banded chromosome preparation as previously described. 23 
In vivo tumorigenicity tests, transplantation to SCID and Nude mice
Scic/scid mice (SCID) and Nude mice were used to test the tumorigenicity of grafted tumor cells. SCID mice were bred under pathogen-free conditions and maintained in the Laboratoire des Déficits Immunitaires et de Rétrovirologie, Faculté de Médecine Laennec, Lyon, France. Nude mice were obtained from IFFA CREDO (St Germain sur l'Arbresle, France). Three Balb/c mice obtained from IFFA CREDO were used as controls.
All the mice were 5 to 8 weeks old, and we used three Nude, two SCID and three Balb/c mice. At the start of the experiment, 20 × 10 6 tumor cells, in 0.5 ml of RPMI without phenol, were inoculated into the subcutaneous tissue and intraperitoneal cavity. Tumor growth was followed each day by palpation and measurement. The mice were killed after palpation of the subcutaneous tumors.
Assays for cellular antigen expression
The synchronization of cells in culture was carried out by adding aphidicolin (5 g/ml to 5 × 10 5 cells in 10 ml of complete medium for 18 h), followed by washing three times with phosphate-buffered saline. For experiments on cellular antigen expression, cultures were seeded at an initial density of 0.2 × 10 6 cells/ml for each experiment. Then, beginning 48 h after initiation of the cultures, followed a period of 6 days either with or without treatment with 0.5% DMSO, 20 nmol PMA and 0.1 mol RA. The control medium was supplemented with 0.1% DMSO, 1 nmol PMA and 5 nmol RA. These concentrations had no antigen expression-stabilizing effect on the DLC 01 cells, as compared with the results obtained in previous experiments. Cell density was maintained at 0.5 × 10 6 cells/ml during the induction process by the addition of fresh growth medium, supplemented with the same concentration of induction agents. The extent of antigen expression was monitored by growth cessation (as determined by cell counts) and by analysis of the expression of cell surface antigens. Viability, as determined by the trypan blue exclusion test, was over 95%.
Phenotyping of canine lymphocytes: immunofluorescent analysis
Polyclonal and monoclonal antibodies (mAbs) used in this study are listed in Table 1 . A polyclonal rabbit anti-human CD3 (Dako, Glostrup, Denmark) that recognizes intracytoplasmic canine CD3⑀ in lymphocyte cells was used to detect T lymphocytes. A mouse monoclonal anti-human HLA-DQ/IOT2d (SPVL3; Immunotech, Marseille, France) was also found to be cross-reactive. 24 Murine anti-human mAb antigranzyme B and anti-perforin (PharmaCell, Paris, France) were used to identify the cytotoxic activity of DLC 01. No data exist as yet on their cross-reactivity with the dog (manuscript in preparation). The rat anti-canine mAbs anti-caCD4, anticaCD5, anti-caCD8 and anti-caCD45 were generously provided by Dr SP Cobbold, Sir Williams Dunn School of Pathology, University of Oxford, UK. The cells were permeabilized in order to study the expression of intracytoplasmic canine CD3, perforin and granzyme B molecules. Flow cytometry analysis of cells was performed on a FACScan equipped with Consort-30 and Lysis software (Becton Dickinson Immunocytometry Systems, Sunnyvale, CA, USA) using a standard indirect immunofluorescent technique. FITC-conjugated goat anti-mouse IgG (Silenus, Melbourne, Australia) and IgM (Jackson Immunoresearch, Shelton, PA, USA), anti-rabbit IgG (Pharmingen, San Diego, CA, USA) and anti-rat IgG1 (Interchim, Paris, France) were used to determine the binding of the primary antibodies. In double-staining experiments on CD4 and CD8, goat anti-mouse Ig conjugated with phycoerythrin (Sigma) was used as the second reagent. Negative controls were performed with unrelated mAbs. DNA labeling of DLC 01 cells was measured by flow cytometry according to a published procedure. 25 
Detection and production of retrovirus particles
DLC 01 cells were grown at a concentration of 10 6 cells per ml in RPMI 1640 medium with 10% heat-inactivated FCS. After induction with 0.5% DMSO for either 2 or 4 days, or after the 5th, 10th, 20th, 30th, 40th or 50th passages, cells were centrifuged at 400 g for 10 min and the cell pellet was examined by electron microscopy, as previously described. 26 Cell suspension (10 6 cells) was fixed in 2% glutaraldehyde and 0.5% paraformaldehyde in 0.1 m phosphate buffer, then post-fixed in 1% OsO 4 . After alcoholic dehydration, the samples were embedded in epoxy resin, and stained ultrathin sections of samples were examined by electron microscopy at the CMEABG (Centre de Microscopie Electronique Appliquée à la Biologie et à la Géologie, Villeurbanne, France) with CM120 (Philips, Eindhoven, Holland). 
Pellet/banded virus particles
Large volumes (5 l) of cell suspensions were used for characterization of the virus particles, which were clarified and concentrated after ultracentrifugation. Briefly, cell culture supernatants were harvested, centrifuged for 15 min at 10 000 g to remove cellular debris, and purified. Clarified supernatants were pelleted through 25% sucrose for 90 min at 100 000 g in a F 28/50 Sorvall rotor, then the supernatant was decanted, TEN buffer (20 mM Tris (pH 7.5), 1 mM EDTA, 1 mM NaCl) was added, and the pellets were resuspended overnight on ice. The resuspended pellets were then spun through a discontinuous 25% to 45% (wt/wt) sucrose gradient in TEN buffer for 2.5 h at 90 000 g. The virus band was collected and fixed, and negatively phosphotungstic acid (PTA)-stained samples were studied by electron microscopy.
Viral protein analysis
Clarified supernatant from DLC 01 cell line was ultracentrifuged through a 20% sucrose cushion. Viruses were resuspended in TNE (20 mm Tris (pH 7.5), 0.1 mm NaCI, 1 mm EDTA) and lysed by adding 1% sodium dodecyl sulfate (SDS) and 10% ␤-mercaptoethanol, heated 2 min at 95°C and immediately thawed on ice. Proteins were resolved on SDS-10% polyacrylamide gels and subjected to electrophoretic transfer on to nitrocellulose membrane (0.45 m pore size; Hybond) in Tris-glycine buffer containing 40% methanol. Proteins were immunodetected by using a chemiluminescence system (ECL kit; Amersham Life Science, Cleveland, OH, USA) with dog serum from MAN.
Reverse transcription (RT) assays: DNA polymerase assays
Rapid reverse transcriptase assays were routinely performed according to published procedures. 27 RT was measured in culture supernatants of DLC 01, DLC 01/Nude, MF cells and, as negative controls, STCL and STCL1.
Results
Establishment of the DLC 01 cell line
During the first weeks after initiation of the culture, cells were allowed to proliferate slowly in culture medium RPMI 1640, supplemented with 20% FCS, without any addition of growth factors. The established cell line, DLC 01, which was found to have a doubling time of 24 h (Figure 1) , was maintained in a culture suspension for over 6 months. The cells showed notable heterogeneity in size and nuclear cytoplasmic ratio (N/C). Their morphology was similar to that of atypical cells ( Figure 2B ). The nuclei were large, often lobulated and indented, with some cytoplasmic granulations, unlike the original cells (Figure 2A ). After treatment with DMSO or PMA, the DLC 01 cells were characterized by variation in size ( Figure  2C ) and large cytoplasm-containing vacuoles. These were polymorphic, irregularly-shaped, and more indented than without treatment, and were 'monocyte-like' with mono-and multi-nucleated nuclei, as revealed by May-Grü nwaldGiemsa staining. Electron microscopic examination of the cells also showed the indented nuclei, numerous ribosomes, abundant ergastoplasm and mitochondria and the presence of lysosomes ( Figure 3A and B) . The karyotype of the DLC 01 cell line consists predominantly of acrocentric and telocentric chromosomes. The number of chromosomes in metaphase cells ranges from 72 to 99; and this is the number found in canine chromosomes. 28, 29 Minute chromosomes were found in several metaphase cells ( Figure 2D ).
Figure 1
Six days growth curve of DLC 01 cells. Cells were seeded at 0.5 × 10 5 cells per ml in RPMI culture medium supplemented with 10% heat inactivated fetal calf serum. Cell counts were assessed by trypan blue dye exclusion every day for six days. Data represent the mean of triplicate experiment. DLC 01 cells are highly tumorigenic when transplanted into Nude and SCID mice with inocula of cells, producing rapidlygrowing, well-vascularized tumors. Six days after inoculation, the abdomen contained moderate ascites with numerous DLC 01 cells. At necropsy the SCID mice had enlarged spleens (120-210 mg, ie three to five times those of the control). Many small tumor nodules were scattered over the liver surface, mesentery, spleen and peritoneum. Tumor cells isolated from the Nude and SCID mice retained their capacity to grow continuously in vitro.
The injection of DLC 01 cells into normal Balb/c mice induced an 'ascites' with micronodules in the peritoneum. These mice survived this injection after 1 week whereas Nude and SCID mice died.
Surface phenotype of DLC 01
The phenotype characterization of primary, uncultured lymph node cells showed 98% CD3 + , 96.5% CD8 + , 97.4% CD5
100% CD45
+ and 99.7% DQ + cells (Figure 4a ). However, these cells did not express CD4 molecules. By contrast, the percentage of CD4 cells in normal peripheral blood lymphocytes is 45.6% (Figure 4e ). After 2 months of culture, DLC 01 cells lacked CD8, CD5 and DQ molecules (Figure 4b ), but still weakly expressed CD3 and CD45 molecules. They constitutively expressed perforin, but no granzyme B (data not shown).
Treatment of DLC 01 cells with PMA, DMSO and RA
Effect of DMSO:
After checking that the leukemic cells grew in DMSO-containing medium, we studied the effect of several concentrations of DMSO on the expression of CD8, CD45 and DQ molecules as well as on cell growth and apoptosis. The extent of changes in morphology correlated closely with growth arrest. The growth in medium containing 0.5% DMSO was approximately the same as that of the control (untreated) cultures during the first 48 h. Thereafter, DMSO suppressed the proliferation of the DLC 01 cells, and induced these to differentiate into CD8 cells. At 72 h, there was a slight but significant increase in the number of differentiating CD8
+ cells (90%) (Figure 4c ), and by 96 h a striking increase was noticed. However, we observed the relative decrease of CD8 expression (77%) after 6 days (Figure 4d ). Continuous exposure to DMSO was generally required for the induction of maximum surface antigen expression. At a concentration of 2%, DMSO apoptosis varied from 13% to 24%. At a concentration of 3% DMSO, cell growth was inhibited, cultures remaining almost stationary; and at 5% DMSO the compound was cytotoxic, with 1% viability after 72 h. However, when these cells were left in culture medium without DMSO, they began to proliferate after 3 weeks. A mutant population was selected by its ability to proliferate continuously in high concentration (3%) DMSO. These resistant cells continued to express CD8 antigen strongly on their membrane. The properties of the original cells, and of DLC 01 cells b From passage 10 to passage 50, the production of the virus required induction with 0.5% DMSO. However, constitutive production occurred after passage 50, and has continued up to the current passage, number 200.
before and after induction by DMSO, are summarized in Table 2 .
Effect of PMA:
PMA treatment resulted in an increase in the expression of T cell markers. Under our experimental conditions, the level of expression was maximal after 2 days, and remained constant thereafter. The expression of membrane CD8, CD45 and DQ molecules induced by PMA was dosedependent, with optimal levels from 10 to 50 nmol/l. Treatment with 100 nmoL PMA also induced apoptosis from 10% to 32%.
Effect of RA:
RA induced better synchronization over 2 days of treatment of DLC 01 cells. All cells became locked in the G1-S phase, and were not induced to differentiate. However, after 2 days of treatment at 0.1 mol, RA induced a high level of apoptosis (92% died in this way). A flow cytometry profile showing the effect of PMA and DMSO on apoptosis in DLC 01 is shown in Figure 5 .
Figure 5
Cell synchrony and apoptosis of DLC 01 cells during culture with or without DMSO and/or PMA. From the third day of culture, the cells were collected using PI, and analyzed for flow cytometry. The hypodiploid peak (percentage of apoptotic cell nuclei) is higher in 2%-treated DMSO cells. A total of 20 000 events was acquired. Results are representative of four experiments.
Detection of virus particles in DLC 01 cells. Electron microscopic characteristics and RT activity:
Both mature and immature extracellular virus particles were seen in thin-section electron micrographs of fixed pelleted DLC 01 cells. Growth of DLC 01 cells in DMSO increased production of the virus, and numerous virus particles were found budding from cell membranes and in the tissue-culture supernatant fluid. Depending on the plane of the section, the core appeared as a two-layered ring-or horseshoe-like structure. The core was usually separated from the envelope by an electronlucent space ( Figure 3C and D) . The combination of the virion shape, budding morphology and the appearance of centrally located core in the mature particles suggest that the virus is of type C, with no obvious type D or type B forms ( Figure 3B ). No particles with eccentric or cylindrically shaped core were observed. Numerous virion-like structures were invariably seen on the ergastoplasm ( Figure 3A) ; they were characterized by translucent centers, and were similar to intracisternal particles of type A. These enveloped, spherical particles were approximately 100 to 120 nm in diameter. Electron micro-graphs of the negatively stained supernatant ( Figure 3D ) revealed typical retrovirus particles, and the PTA caused considerable distortion, producing tails on some particles. Such tails have also been described in PTA negatively stained type C particles. 30 DLC 01 cells would thus seem to be a constitutive producer of retrovirus particles.
Evidence for the presence of retroviruses in the DLC 01 supernatant:
Manganese-dependent RT activity was observed in the supernatant of the DLC 01 and MF cells, but not in those of the healthy control dogs (STCL and STCL1) or the DLC 01/Nude, and no RT activity was seen when manganese was replaced by magnesium. Peak virus budding, and subsequent release into the extracellular fluid, as measured by electron microscopy and DNA polymerase activity, occurred 48 h and 96 h, respectively, after induction by 0.5% DMSO.
Viral protein analysis
Two bands were stained by the MAN's sera. The antigenic proteins were located at apparent Mr: 49 000 and 32 000 ( Figure 6 ).
Discussion
DLC 01 is the first lymphoid T CD8
+ cell line growing spontaneously isolated from a dog suffering from Sézary syndrome. A large granular canine leukemia CD8
+ cell line which expresses TCR-␣␤ + , named CLG90, was presented during the
Figure 6
Analysis of viral protein. Viral proteins were extracted as described in Materials and methods, separated on an SDS-10% polyacrylamide gel, and subjected to electrophoretic transfer on to nitrocellulose membrane for immunoblotting with serum from MAN (1) and from healthy dog for control (2) . Two bands were stained by the MAN's sera and the antigenic proteins were located at apparent Mr: 49 000 and 32 000.
last Canine Leukocyte Antigen Workshop in 1993, 31 but has not so far given rise to any publications. The DLC 01 cells appear to be 'immortalized' as they have now been growing in culture for 6 months, and no longer require IL-2. In contrast to cultures of lymph node lymphocytes from other cases of MF that we have studied (no published data), DLC 01 cells are capable of growing in suspension in the absence of growth factors. Their doubling time is 24 h. The number of chromosomes and the predominant presence of telocentric and acrocentric chromosomes 28, 29 and the canine specificity of the mAbs used are compatible with a canine origin. After 2 months in culture, the DLC 01 cells lacked CD8, CD5 and DQ molecules, but still expressed CD3, CD45 and perforin. Perforin was also expressed in situ on frozen sections (data not shown). Therefore, perforin could be constitutively expressed on DLC 01 cells and this molecule is constitutively associated with TCR-␥␦ T cells 32, 33 in humans and can be detected in vivo in activated T cells of animals and humans challenged with an allo Ag or viral Ag. A positive correlation has been found between the expression of at least one of these molecules and the cytotoxic potential of the cells. 32 Preliminary results for dogs (manuscript in preparation) show that perforin and granzyme B are expressed in peripheral mononuclear cells and in eight out of nine cases of CTCL and leukemic CD8
+ cells. In line with this data, Moore et al 8 showed that 18 out of 27 cases of CTCL in dogs were TCR-␥␦ CD8 + . Unfortunately, the anti-TCR-␥␦ antibody produced by Moore et al 9 is not available. The phenotype properties of this cell line were relatively easy to study, in so far as surface antigen expression was induced by the treatment of DLC 01 cells with DMSO and PMA. The addition of these differentiation inducers, including polar-planer compounds such as DMSO 34 upregulates the surface membrane molecules CD8, CD45 and DQ on DLC 01 cells, as found on mature CD8 + lymphocytes. In the present case, 48 h exposure to DMSO or PMA was necessary in order to observe any molecule upregulation, and continuous exposure to these compounds was generally required to induce maximal molecule upregulation. Also, it was found that after 4 days of treatment with DMSO, DLC 01 cells had become locked into a G1-S phase, and no longer divided (monitored by thymidine incorporation, data not shown), and at high concentration (3%) apoptosis was induced.
An interesting property of this cell line studied was its ability to produce virus particles, with a morphology suggestive of a type-C retrovirus and Mn2+ dependent reverse transcriptase activity. Only two, out of the family of seven retroviruses, display such a Mn2+ dependent activity: spumaretrovirus and the so-called 'mammalian' type-C retroviruses 30 such as FeLV and MuLV. Both particle morphology and the absence of any foamy cytopathic effect suggest that the particles we observed belong to the latter retroviral family. Assembly and budding of type-C retroviruses take place simultaneously at the plasma membrane, so that no intracellular particles can be observed. However, overexpression of Gag proteins 35 has been shown to lead to cytoplasmic assembly of viral particles before budding through cellular membranes, usually observed with type-A, -B or -C retroviruses. Conversely, a point mutation in the matrix proteins of type-D retroviruses led to its assembly at the cell membrane like typical type-C retroviruses. 36 Thus, the intracellular particles that we observed could possibly correspond to a new type-C retrovirus which would efficiently collect in the cytoplasm. Alternatively, the DLC 01 could produce both a type-C retrovirus and endogenous defective intracisternal type-A particles (IAP). IAP are frequently expressed in undifferentiated or tumoral cells. 36 The typical simultaneous assembly and budding images that we observed at the plasma membrane of DLC 01 cells are in better agreement with this second explanation. In this case, we used DMSO before negative stained or embedding for electron microscopy. A particular property of DMSO is that of stabilizing enveloped viruses, 34 and in the present study, DLC 01 treated with DMSO expressed CD8 antigen after 96 h, this being the point at which production of the virus reached a maximum with 'mature' morphology. The fact that large numbers of virions were found in association with the DLC 01 cell line suggests that this may well be a good source of the virus.
Retroviruses are known to be involved in the causation of certain leukemias and sarcomas in a number of species 30, [37] [38] [39] although this etiology has not yet been demonstrated in dogs. The role of retroviruses in the etiology of canine non-Hodgkin's lymphoma (NHL) is still controversial 40 and up to now, there is no canine retrovirus isolated from a cell line. However, RT activity has been reported in a supernatant of a lymphosarcoma cell line. 41, 42 These publications are not recent, and no retroviruses were clearly characterized. Two recent papers report a retrovirus in a leukemic dog, 43 and a retrovirus with manganese-dependent RT activity in immunosuppressed dogs. 44 However, the isolation of complete, welldefined virus particles in those dogs has yet to be achieved. However, the molecular weights of immunoprecipitated proteins with the MAN's sera are in line with viral proteins (capsid proteins) present in murine leukemia retrovirus.
The particular interest of the DLC 01 cell line is that it produces a canine retrovirus, which we are cloning, and more specific studies on the distribution of this novel virus among ill and healthy dogs are currently in progress.
